Total Funding
37
46
Total FundingPost-IPO Equity raised
Growth Score
-11 pts
Heat Score
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
266651
Wize Pharma is a pharmaceutical company that focuses on the treatment of ophthalmic disorders, including DES.
- Yossi Keret: Board MemberPast Role: Weebit Nano, CEO & Founder
- Noam Danenberg: Co-founder and CEO
About the Company
Wize Pharma is a pharmaceutical company that focuses on the treatment of ophthalmic disorders, including DES. The company's strategy involves engaging local or multinational distributors to handle the distribution of LO2A.
Wize Pharma was founded in 1982 and headquartered in HaMerkaz, Israel.
